Quantcast
Home / Practice Areas / Personal Injury and Tort / Pfizer faces first trial on Neurontin suicide claim

Pfizer faces first trial on Neurontin suicide claim

Pfizer, Inc., the world’s biggest drugmaker, goes to trial today on claims its epilepsy medication Neurontin increases the risk of suicide, in a case the judge called “very tough” for the plaintiffs to win. The trial will be the first of what plaintiffs’ lawyers say are about 1,200 cases.